News & Events
Dr. Parker's research program was profiled by OZY for Autism Awareness Day 2018
April 2nd, 2018
Oxytocin treatment trial paper voted a Top 10 Most Notable Paper for 2017
Our team’s oxytocin treatment trial paper was voted a Top 10 Most Notable Paper for 2017 by SPECTRUM.
December 22th, 2017
Jesus Madrid awarded DARE doctoral fellowship
The DARE (Diversifying Academia, Recruiting Excellence) Doctoral Fellowship Program awards two-year fellowships to advanced doctoral students who want to investigate and prepare for academic careers and whose presence will help diversify the professoriate.
August 20th, 2016
Michael Mariscal presents summer research at the undergraduate HBREX poster symposium
Michael Mariscal presented his ongoing summer research investigating the effect of intranasal oxytocin on contagious laughing and yawning in children with autism. Michael was one of thirty undergraduate students who participated in the Human Biology Research Exploration Program (HB-REX), a competitive mentored research program sponsored by the Department of Human Biology.
August 10th, 2016
Scope's Q&A with Dr. Parker
Scope, a blog produced by the Stanford University School of Medicine, interviewed Dr. Parker about studying potential biomarkers and treatments for autism. In the interview, she talks about her recent findings that suggest oxytocin and vasopressin may be implicated in autism. She also talks about how she became an autism researcher and future directions of the lab.
May 19th, 2016
Dr. Parker participates in the OARC & NIMH neurodevelopmental disorders workshop
Dr. Parker discusses her research on the biological underpinnings of ASD at the Office of Autism Research Coordination (OARC) and NIMH's Loss of Skills and Onset Patterns in Neurodevelopmental Disorders: Understanding the Neurobiological Mechanisms workshop. The workshop focused on the state of the science with regard to onset patterns in ASD and related disorders, including developmental regression, and the biological mechanisms that may account for these onset patterns.
February 19th, 2016
Dr. Parker named Kavli Fellow
The Kavli program honors scientific leaders under 45 years of age who have made significant contributions to their scientific field.
Dr. Parker named Associate Member of ACNP
Dr. Parker was named an Associate Member of the American College of Neuropsychopharmacology (ACNP). The core purpose of the ACNP is to advance scientific understanding of and to facilitate communication about disorders of the brain and behavior in order to further their prevention and treatment. ACNP consists of leading brain scientists and membership is by election.
Jesus Madrid passes Ph.D. qualifying examination
Jesus successfully presented his Ph.D. proposal entitled, "Social and biological outcomes of neonatal imitation in mother-reared rhesus macaques (Macaca mulatta)" to his thesis advisory committee.
September 14th, 2015
Dr. Parker & collaborators awarded a Stanford Neurosciences Institute Seed Grant
Dr. Parker, in collaboration with Dr. Alexander Urban, Dr. Megan Albertelli, and Dr. Joachim Hallmayer, was awarded a $200,000 SNI Seed Grant. Together, they will create an advanced transgenic animal model of autism. Future development of this model will seek to accelerate the discovery of autism biomarkers and novel drug targets, and streamline the development of the first effective medications to improve social functioning in people with autism.
August 27th, 2015
Dr. Parker served on the planning committe and as a workshop member for the NICHD Oxytocin in Intellectual and Developmental Disabilities workshop
This workshop focused on the state of science with regard to oxytocin as a biomarker of and therapeutic for autism and related neurodevelopmental disorders.
Dr. Karen Parker and Dr. Deb Karhson awarded SUMS seed grant
Dr. Karhson will be utilizing the SUMS grant to investigate the potential of mass spectrometry to measure neuromodulatory lipids and neuropeptides in cerebrospinal fluid and blood samples.
August 21st, 2015
Dr. Parker awarded a Simons Foundation grant
Dr. Parker received a SFARI Research Award (entitled "Detecting and Treating Social Impairments in a Monkey Model") to continue to develop her primate model of naturally occurring social impairments.
August 1st, 2015
New research study on vasopressin levels and social deficits published in PLOS ONE
This report found that blood vasopressin concentrations can be used both as a surrogate for brain vasopressin activity in humans and as a robust biomarker of theory of mind ability in children with autism. These findings suggest that the vasopressin signaling pathway may be a promising therapeutic target by which to improve social cognition in individuals with autism. The full article can be found here.
July 22nd, 2015
Dr. Parker awarded George A. Miller Award for the most outstanding article in general psychology
This annual award recognizes the most outstanding article in general psychology. Dr. Parker received this award along with Drs. Gregory Miller and Edith Chen for their article published in Psychological Bulletin titled, “Psychological stress in childhood and susceptibility to the chronic diseases of aging: Moving toward a model of behavioral and biological mechanisms.”
Lisa and Raena graduate from Stanford with Honors
Lisa Jackson and Raena Sumiyoshi graduated from Stanford with bachelor's degrees with honors in Human Biology. In addition, Lisa was awarded the Bernard and Estelle Shuer Award for Outstanding Neuroscience Research in Human Biology and Raena was awarded the Center for Teaching & Learning Award for Excellence in Honors Presentations in Human Biology.
June 14th, 2015
Dr. Özge Öztan's findings from the Society for Neuroscience's annual meeting covered by Spectrum News.
Dr. Öztan presented data from her study investigating CSF and blood biomarkers of impaired social functioning in a rhesus monkey model of autism.
November 17th, 2014
Simons Foundation's Q&A with Dr. Parker
The Simons Foundation's SFARI.org interviewed Dr. Parker about studying social behavior in rhesus monkeys. In the interview, she talks about why we are using rhesus monkeys as an animal model for humans with autism, how we are measuring social functioning, and what implications this research will have for individuals with autism.
November 4th, 2014
Dr. Özge Öztan receives CHRI Postdoctoral Award
Dr. Özge Öztan received a Stanford Child Health Research Institute (CHRI) Postdoctoral Support Program Award.
June 1st, 2014